Neuroscience researchers at Seattle Children’s made an unusual discovery in 2016: an uncharted area of the brain necessary to breathing.
We helped show that two stem cell transplants, plus immunotherapy, significantly increased survival for children with high-risk neuroblastoma.
A surgical paradigm shift makes it possible for kids with severely restricted airways to breathe on their own.
Seattle Children’s geneticists are playing a key role in characterizing the devastating damage to newborns caused by congenital Zika syndrome.
The incredible growth of Seattle Children's Research Institute over the past 10 years has attracted new researchers, boosted funding and advanced treatments and therapies for children.
We’re investing hundreds of millions of dollars to develop, manufacture and test cell therapies that aim to cure diseases at the source.
New research at Seattle Children's demonstrates that the Specific Carbohydrate Diet can induce clinical remission in ulcerative colitis and Crohn's disease.
Current cancer therapies could inhibit intractable epileptic seizures caused by mutations in a gene that produces the mTOR protein.
By taking leadership roles in national organizations, our faculty help improve pediatric care and the health and well-being of children and teens.
A drug derived from sea anemone venom demonstrates the potential to suppress inflammation without the severe side effects of existing therapies
Follow us for the latest Seattle Children’s news and events, or to share your story with us.